This document constitutes a regulatory disclosure filed with both BSE Limited and the National Stock Exchange of India Limited regarding an upcoming board meeting.
The Board of Directors of DCM Shriram Fine Chemicals Limited will hold a meeting on Saturday, November 14, 2026. The primary agenda for this meeting is to consider and approve the company's Unaudited Financial Results for both the quarter ended September 30, 2026 (Q2 FY2027) and the half year ended September 30, 2026 (H1 FY2027). The results will be prepared on both a Standalone and Consolidated basis.
This intimation is made in compliance with Regulation 29 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The approval of the financial results themselves is a requirement under Regulation 33 of the same regulations.
The official notice for this board meeting has been made available on the company's website at www.dsfcl.com.
The disclosure was signed by Kokila Arora, Company Secretary & Compliance Officer (Membership No. ACS 21670), and was digitally signed on November 07, 2026, at 21:41:31 IST.